
In the first part of a two-part interview, Paz Vellanki of Precision for Medicine explains what sponsors should bring to early FDA meetings and how manufacturing and assay readiness can delay rare disease trials.
Gil Roth, Founder and President of the Pharma & Biopharma Outsourcing Association speaks with BioPharm International.
Gil Roth, Founder and President of Pharma & Biopharma Outsourcing Association (PBOA), spoke with BioPharm International about the benefits of a trade association for the Pharma and Biopharma industries, and the top issues on PBOA’s agenda.